This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates-revisions: Archive
Crocs (CROX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Crocs (CROX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CROXPositive Net Change RVLVNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Compared to Estimates, Sirius XM (SIRI) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Sirius XM (SIRI) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
SIRIPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Lincoln Electric (LECO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Lincoln Electric (LECO) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
LECONegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Kellanova (K) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Kellanova (K) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
KNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Roblox (RBLX) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Roblox (RBLX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
RBLXNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
MasterCard (MA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for MasterCard (MA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MANegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Insight Enterprises (NSIT) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Insight Enterprises (NSIT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
NSITNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
First Foundation (FFWM) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for First Foundation (FFWM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FFWMNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Wall Street Analysts See a 29.37% Upside in SiriusPoint (SPNT): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 29.4% upside potential for SiriusPoint (SPNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
SPNTNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Zevra Therapeutics (ZVRA) Have the Potential to Rally 117.11% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Zevra Therapeutics (ZVRA) points to an 117.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ZVRAPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think uniQure (QURE) Could Surge 142.67%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 142.7% upside potential for uniQure (QURE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
QUREPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Hillman Solutions Corp. (HLMN) Could Surge 36.75%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 36.8% in Hillman Solutions Corp. (HLMN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
HLMNNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 25.23% Upside in GDS Holdings (GDS): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in GDS Holdings (GDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
GDSNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Dyne Therapeutics (DYN) Have the Potential to Rally 285.57% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Dyne Therapeutics (DYN) points to a 285.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
DYNPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Compared to Estimates, Columbia Financial (CLBK) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Columbia Financial (CLBK) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
CLBKNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Allegheny Technologies (ATI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Allegheny Technologies (ATI) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ATIPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Quanta Services (PWR) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Quanta Services (PWR) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
PWRPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Xylem (XYL) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Xylem (XYL) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
XYLNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Lam Research (LRCX) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Lam Research (LRCX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
LRCXNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Here's What Key Metrics Tell Us About Kimco Realty (KIM) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Kimco Realty (KIM) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
KIMNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Air Products and Chemicals (APD) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Air Products and Chemicals (APD) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
APDPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Euronet Worldwide (EEFT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Euronet Worldwide (EEFT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
EEFTNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
IARTNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Willis Towers Watson (WTW) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Willis Towers Watson (WTW) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
WTWPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, BigCommerce (BIGC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for BigCommerce (BIGC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
earnings earnings-estimates-revisions earnings-surprise